Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated (Deficit) Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   16,210,776        
Beginning balance at Dec. 31, 2022 $ 63,631 $ 16 $ 109,138 $ 11,753 $ 757 $ (58,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock in asset acquisition (in shares)   100,000        
Issuance of common stock in asset acquisition $ 1,000 $ 1 999      
Repurchases of common shares (in shares) (69,628) (69,628)        
Repurchases of common shares $ (588)         (588)
Issuance of common stock to convert outstanding convertible notes (in shares)   800,000        
Issuance of common stock to convert outstanding convertible notes 2,400 $ 1 2,399      
Issuance of common stock upon exercise of warrant (in shares)   400,000        
Issuance of common stock upon exercise of warrants $ 1,200   1,200      
Issuance of common stock upon stock options cashless exercise (in shares) 1,348,000 603,881        
Issuance of warrants with unsecured promissory note $ 398   398      
Treasury shares repurchased to satisfy tax withholding obligations (5,379)         (5,379)
Unrealized gain (loss) on marketable securities (1,057)       (1,057)  
Stock-based compensation 4,560   4,560      
Net loss $ (16,782)     (16,782)    
Ending balance (in shares) at Dec. 31, 2023 18,045,029 18,045,029        
Ending balance at Dec. 31, 2023 $ 49,383 $ 18 118,694 (5,029) (300) (64,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchases of common shares (in shares) 0          
Issuance of common stock for cash, net of offering cost (in shares)   5,829,000        
Issuance of common stock for cash, net of offering cost $ 7,594 $ 2 7,592      
Issuance of treasury shares as collateral for a loan (in shares) 6,000,000 6,000,000        
Issuance of treasury shares as collateral for a loan $ 0 $ 3 (3)      
Unrealized gain (loss) on marketable securities 102       102  
Stock-based compensation 3,638   3,638      
Net loss $ (53,364)     (53,364)    
Ending balance (in shares) at Dec. 31, 2024 29,874,029 29,874,029        
Ending balance at Dec. 31, 2024 $ 7,353 $ 23 $ 129,921 $ (58,393) $ (198) $ (64,000)